Sector portfolio · VC firm · United Kingdom
Abingworth's Biotech portfolio
Abingworth has backed 18 Biotech startups in rounds we track, $2.4B between them, shown by the stage each has reached. The best-funded is Phathom Pharmaceuticals.
Funding by segment
- Series C and later$1.3B9
- Series A$465M5
- Stage not reported$645M4
Where they are based
- United States11$1.6B
- United Kingdom5$248M
- Australia1$438M
- Switzerland1$92M
United States
United Kingdom
Australia
SwitzerlandFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M3
- $50M to $250M12
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 18 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States11
- United Kingdom5
- Australia1
- Switzerland1
Startups by country, 4 countries in all.
Segment by segment
Series C and later
9 startups · $1.3B raised
AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M- SSutroVaxUnited States$167M
Atsena TherapeuticsAtsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments forUnited States$150M
PersonalisPersonalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.United States$125M
Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
Hydra BiosciencesHydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 2001.United States$95M- STSynosia TherapeuticsSynosia Therapeutics develops and commercializes products for unmet medical needs in psychiatry and neurology.Switzerland$92M
Pathwork DiagnosticsPathwork Diagnostics develops and delivers molecular diagnostic solutions for oncology.United States$64M
Series A
5 startups · $465M raised
Jasper TherapeuticsJasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.United States$167M- CTCytospire TherapeuticsUnited Kingdom$121M
IFM TherapeuticsIFM Therapeutics is a biopharmaceutical company based in Boston, Massachusetts, focused on developing innovative therapies for canUnited States$83M- RTR1 TherapeuticsUnited States$78M
VirionHealthVirionHealth is a biotechnology company that primarily focuses on developing therapies for respiratory viral infections.United Kingdom$17M
Stage not reported
4 startups · $645M raised
Phathom PharmaceuticalsPhathom Pharmaceuticals is a biopharmaceutical company.United States$530M
Chroma TherapeuticsChroma Therapeutics is a biotechnology company located in Oxford/Abingdon, UK.United Kingdom$78M
Avila TherapeuticsAvila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases.United States$32M- IPIS PharmaIS Pharma developed, acquired and commercialized pharmaceutical and medical devices in the areas of critical care, oncology and neurology.United Kingdom$5.7M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Abingworth as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Abingworth?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.